Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia

Abdul-Quader, 2013, Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review, AIDS Behav., 17, 2878, 10.1007/s10461-013-0593-y

Abecasis, 2006, Investigation of baseline susceptibility to protease inhibitors in HIV-1 subtypes C, F, G and CRF02_AG, Antivir. Ther., 11, 581, 10.1177/135965350601100512

Abecasis, 2013, HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics, Retrovirology, 10, 7, 10.1186/1742-4690-10-7

Adojaan, 2005, Predominance of a rare type of HIV-1 in Estonia, J. Acquir. Immune Defic. Syndr., 39, 598

Altaf, 2009, High prevalence of HIV infection among injection drug users (IDUs) in Hyderabad and Sukkur, Pakistan, J. Pak. Med. Assoc., 59, 136

Angelis, 2015, Global dispersal pattern of HIV type 1 subtype CRF01_AE: a genetic trace of human mobility related to heterosexual sexual activities centralized in Southeast Asia, J. Infect. Dis., 211, 1735, 10.1093/infdis/jiu666

Archibald, 2013, Geographical and temporal variation of injection drug users in Pakistan, Sex. Transm. Infect., 89, ii18, 10.1136/sextrans-2012-050775

Armstrong, 2015, Undiagnosed HIV among people who inject drugs in Manipur, India, AIDS Care, 27, 288, 10.1080/09540121.2014.972322

Aspinall, 2014, Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis, Int. J. Epidemiol., 43, 235, 10.1093/ije/dyt243

Avi, 2011, Emerging transmitted drug resistance in treatment-naïve human immunodeficiency virus-1 CRF06_cpx-infected patients in Estonia, Scand. J. Infect. Dis., 43, 122, 10.3109/00365548.2010.526956

Azim, 2002, Injecting drug users in Bangladesh: prevalence of syphilis, hepatitis, HIV and HIV subtypes, AIDS, 16, 121, 10.1097/00002030-200201040-00015

Baesi, 2014, Subtype classification of Iranian HIV-1 sequences registered in the HIV databases, 2006-2013, PLoS One, 9, 10.1371/journal.pone.0105098

Baeten, 2007, HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads, J. Infect. Dis., 195, 1177, 10.1086/512682

Balode, 2004, Rapid epidemic spread of HIV type 1 subtype A1 among intravenous drug users in Latvia and slower spread of subtype B among other risk groups, AIDS Res. Hum. Retrovir., 20, 245, 10.1089/088922204773004978

Balode, 2012, Phylogenetic analysis of the Latvian HIV-1 epidemic, AIDS Res. Hum. Retrovir., 28, 928, 10.1089/aid.2011.0310

Bannister, 2006, HIV-1 subtypes and response to combination antiretroviral therapy in Europe, Antivir. Ther., 11, 707, 10.1177/135965350601100617

Barré-Sinoussi, 1983, Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS), Science, 220, 868, 10.1126/science.6189183

Bártolo, 2009, Highly divergent subtypes and new recombinant forms prevail in the HIV/AIDS epidemic in Angola: new insights into the origins of the AIDS pandemic, Infect. Genet. Evol., 9, 672, 10.1016/j.meegid.2008.05.003

Bártolo, 2011, Origin and epidemiological history of HIV-1 CRF14_BG, PLoS One, 6, 10.1371/journal.pone.0024130

Baryshev, 2012, Genetic characterization of an isolate of HIV type 1 AG recombinant form circulating in Siberia, Russia, Arch. Virol., 157, 2335, 10.1007/s00705-012-1442-4

Baryshev, 2014, HIV-1 genetic diversity in Russia: CRF63_02A1, a new HIV type 1 genetic variant spreading in Siberia, AIDS Res. Hum. Retrovir., 30, 592, 10.1089/aid.2013.0196

Beyrer, 1998, HIV type 1 subtypes in Malaysia, determined with serologic assays: 1992–1996, AIDS Res. Hum. Retrovir., 14, 1687, 10.1089/aid.1998.14.1687

Beyrer, 2000, Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia, AIDS, 14, 75, 10.1097/00002030-200001070-00009

Beyrer, 2009, Characterization of the emerging HIV type 1 and HCV epidemics among injecting drug users in Dushanbe, Tajikistan, AIDS Res. Hum. Retrovir., 25, 853, 10.1089/aid.2008.0206

Bhanja, 2005, Determination of gag and env subtypes of HIV-1 detected among injecting drug users (IDUs) in Manipur, India: evidence for intersubtype recombination, Virus Res., 114, 149, 10.1016/j.virusres.2005.06.008

Bobkov, 1994, Identification of an env G subtype and heterogeneity of HIV-1 strains in the Russian Federation and Belarus, AIDS, 8, 1649, 10.1097/00002030-199412000-00002

Bobkov, 2001, An HIV type 1 subtype A strain of low genetic diversity continues to spread among injecting drug users in Russia: study of the new local outbreaks in Moscow and Irkutsk, AIDS Res. Hum. Retrovir., 17, 257, 10.1089/088922201750063188

Bobkov, 2004, Temporal trends in the HIV-1 epidemic in Russia: predominance of subtype A, J. Med. Virol., 74, 191, 10.1002/jmv.20177

Bobkov, 2004, An HIV type 1 subtype A outbreak among injecting drug users in Kazakhstan, AIDS Res. Hum. Retrovir., 20, 1134, 10.1089/aid.2004.20.1134

Bobkova, 2013, Current status of HIV-1 diversity and drug resistance monitoring in the former USSR, AIDS Rev., 15, 204

Bontell, 2013, Molecular dating of HIV-1 subtype C from Bangladesh, PLoS One, 8, 10.1371/journal.pone.0079193

Braitstein, 2006, Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort, AIDS, 20, 323, 10.1097/01.aids.0000198091.70325.f4

Brenner, 2003, A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors, AIDS, 17, F1, 10.1097/00002030-200301030-00001

Brown, 1996, HIV type 1 subtypes in Malaysia include B, C, and E, AIDS Res. Hum. Retrovir., 12, 1655, 10.1089/aid.1996.12.1655

Campbell-Yesufu, 2011, Update on human immunodeficiency virus (HIV)-2 infection, Clin. Infect. Dis., 52, 780, 10.1093/cid/ciq248

Caplinskas, 2013, Distinct HIV type 1 strains in different risk groups and the absence of new infections by drug-resistant strains in Lithuania, AIDS Res. Hum. Retrovir., 29, 732, 10.1089/aid.2012.0312

Casado, 2000, Different distribution of HIV type 1 genetic variants in European patients with distinct risk practices, AIDS Res. Hum. Retrovir., 16, 299, 10.1089/088922200309403

Centers for Disease Control, 1981, Pneumocystis pneumonia–Los Angeles, MMWR Morb. Mortal. Wkly Rep., 30, 250

Centers for Disease Control, 1982, Update on acquired immune deficiency syndrome (AIDS)–United States, MMWR Morb. Mortal. Wkly Rep., 31, 513

Chabadová, 2014, Distribution of HIV-1 subtypes circulating in Slovakia (2009-2012), Acta Virol., 58, 317, 10.4149/av_2014_04_317

Charneau, 1994, Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group, Virology, 205, 247, 10.1006/viro.1994.1640

Chen, 2009, Molecular epidemiological study of HIV-1 CRF01_AE transmission in Hong Kong, J. Acquir. Immune Defic. Syndr., 51, 530, 10.1097/QAI.0b013e3181aac516

Chow, 2013, Molecular diversity of HIV-1 among people who inject drugs in Kuala Lumpur, Malaysia: massive expansion of circulating recombinant form (CRF) 33_01B and emergence of multiple unique recombinant clusters, PLoS One, 8, 10.1371/journal.pone.0062560

Chow, 2014, A newly emerging HIV-1 recombinant lineage (CRF58_01B) disseminating among people who inject drugs in Malaysia, PLoS One, 9, 10.1371/journal.pone.0085250

Ciccozzi, 2007, An outbreak of HIV-1 subtype G among Italian injecting drug users, AIDS, 21, 1213, 10.1097/QAD.0b013e32813aee1a

Clavel, 1986, Isolation of a new human retrovirus from West African patients with AIDS, Science, 233, 343, 10.1126/science.2425430

Cohen, 2011, Prevention of HIV-1 infection with early antiretroviral therapy, N. Engl. J. Med., 365, 493, 10.1056/NEJMoa1105243

D’arc, 2015, Origin of the HIV-1 group O epidemic in western lowland gorillas, Proc. Natl. Acad. Sci. U. S. A., 112, E1343, 10.1073/pnas.1502022112

Delgado, 2002, Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure, J. Acquir. Immune Defic. Syndr., 29, 536, 10.1097/00126334-200204150-00016

Deng, 2008, The epidemic origin and molecular properties of B’: a founder strain of the HIV-1 transmission in Asia, AIDS, 22, 1851, 10.1097/QAD.0b013e32830f4c62

Des Jarlais, 2011, HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years, Subst. Use Misuse, 46, 131, 10.3109/10826084.2011.521456

Des Jarlais, 2013, High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review, BMC Public Health, 13, 53, 10.1186/1471-2458-13-53

Díez-Fuertes, 2015, Bayesian phylogeographic analyses clarify the origin of the HIV-1 subtype A variant circulating in former Soviet Union’s countries, Infect. Genet. Evol., 33, 197, 10.1016/j.meegid.2015.05.003

Duque, 2003, Human immunodeficiency virus type 1 recombinant B/G subtypes circulating in Coimbra, Portugal, Clin. Microbiol. Infect., 9, 422, 10.1046/j.1469-0691.2003.00541.x

Ekouevi, 2014, Antiretroviral therapy response among HIV-2 infected patients: a systematic review, BMC Infect. Dis., 14, 461, 10.1186/1471-2334-14-461

Eremin, 2011, A new unique recombinant HIV type 1 isolated from a child born to an HIV-infected mother, AIDS Res. Hum. Retrovir., 27, 1323, 10.1089/aid.2011.0112

Esteves, 2002, Molecular epidemiology of HIV type 1 infection in Portugal: high prevalence of non-B subtypes, AIDS Res. Hum. Retrovir., 18, 313, 10.1089/088922202753519089

Esteves, 2003, Spreading of HIV-1 subtype G and envB/gagG recombinant strains among injecting drug users in Lisbon, Portugal, AIDS Res. Hum. Retroviruses, 19, 511, 10.1089/088922203766774568

Eyzaguirre, 2007, Genetic characterization of HIV-1 strains circulating in Kazakhstan, J. Acquir. Immune Defic. Syndr., 46, 19, 10.1097/QAI.0b013e318073c620

Faria, 2014, The early spread and epidemic ignition of HIV-1 in human populations, Science, 346, 56, 10.1126/science.1256739

Ferdats, 1999, An HIV type 1 subtype A outbreak among injecting drug users in Latvia, AIDS Res. Hum. Retrovir., 15, 1487, 10.1089/088922299310007

Friedman, 2009, Theorizing “Big Events” as a potential risk environment for drug use, drug-related harm and HIV epidemic outbreaks, Int. J. Drug Policy, 20, 283, 10.1016/j.drugpo.2008.10.006

Gallo, 1984, Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS, Science, 224, 500, 10.1126/science.6200936

Gao, 1992, Human infection by genetically diverse SIVSM-related HIV-2 in west Africa, Nature, 358, 495, 10.1038/358495a0

Gao, 1999, Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes, Nature, 397, 436, 10.1038/17130

Giannou, 2015, Condom effectiveness in reducing heterosexual HIV transmission: a systematic review and meta-analysis of studies on HIV serodiscordant couples, Expert Rev. Pharmacoecon. Outcomes Res., 1

Glauser, 1984, Clinical and epidemiological survey of acquired immune deficiency syndrome in Europe, Eur. J. Clin. Microbiol., 3, 55, 10.1007/BF02032823

Goswami, 2014, An assessment of an HIV prevention intervention among people who inject drugs in the states of Manipur and Nagaland, India, Int. J. Drug Policy, 25, 853, 10.1016/j.drugpo.2014.04.016

Graf, 1998, Cloning and characterization of a virtually full-length HIV type 1 genome from a subtype B’-Thai strain representing the most prevalent B-clade isolate in China, AIDS Res. Hum. Retrovir., 14, 285, 10.1089/aid.1998.14.285

Gürtler, 1994, A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon, J. Virol., 68, 1581, 10.1128/JVI.68.3.1581-1585.1994

Habekova, 2010, Genetic subtypes of HIV type 1 circulating in Slovakia, AIDS Res. Hum. Retrovir., 26, 1103, 10.1089/aid.2009.0220

Han, 2013, High prevalence of HIV-1 intersubtype B’/C recombinants among injecting drug users in Dehong, China, PLoS One, 8

Han, 2015, Development of an HIV-1 subtype panel in China: isolation and characterization of 30 HIV-1 primary strains circulating in China, PLoS One, 10

Harris, 2005, Genomic characterization of a novel HIV type 1 B/G intersubtype recombinant strain from an injecting drug user in Germany, AIDS Res. Hum. Retrovir., 21, 654, 10.1089/aid.2005.21.654

Hatzakis, 2015, Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme, Addiction, 110, 1453, 10.1111/add.12999

He, 2012, A comprehensive mapping of HIV-1 genotypes in various risk groups and regions across China based on a nationwide molecular epidemiologic survey, PLoS One, 7, 10.1371/journal.pone.0047289

Hemelaar, 2011, Global trends in molecular epidemiology of HIV-1 during 2000-2007, AIDS, 25, 679, 10.1097/QAD.0b013e328342ff93

Hersh, 1991, Acquired immunodeficiency syndrome in Romania, Lancet, 338, 645, 10.1016/0140-6736(91)91230-R

Hersh, 1993, Risk factors for HIV infection among abandoned Romanian children, AIDS, 7, 1617, 10.1097/00002030-199312000-00012

Holguín, 2008, Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain, Curr. HIV Res., 6, 327, 10.2174/157016208785132455

Huang, 2014, Patients infected with CRF07_BC have significantly lower viral loads than patients with HIV-1 subtype B: mechanism and impact on disease progression, PLoS One, 9, 10.1371/journal.pone.0114441

Ibe, 2010, HIV-2 CRF01_AB: first circulating recombinant form of HIV-2, J. Acquir. Immune Defic. Syndr., 54, 241, 10.1097/QAI.0b013e3181dc98c1

Jahanbakhsh, 2013, Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011, PLoS One, 8, 10.1371/journal.pone.0061864

Jahanbakhsh, 2013, Molecular epidemiology of HIV type 1 infection in Iran: genomic evidence of CRF35_AD predominance and CRF01_AE infection among individuals associated with injection drug use, AIDS Res. Hum. Retrovir., 29, 198, 10.1089/aid.2012.0186

Junqueira, 2016, HIV-1 subtype B: traces of a pandemic, Virology, 495, 173, 10.1016/j.virol.2016.05.003

Kato, 1999, Genetic similarity of HIV type 1 subtype E in a recent outbreak among injecting drug users in northern Vietnam to strains in Guangxi Province of southern China, AIDS Res. Hum. Retrovir., 15, 1157, 10.1089/088922299310250

Kato, 2001, Closely related HIV-1 CRF01_AE variant among injecting drug users in northern Vietnam: evidence of HIV spread across the Vietnam–China border, AIDS Res. Hum. Retrovir., 17, 113, 10.1089/08892220150217201

Kazennova, 2014, HIV-1 genetic variants in the Russian Far East, AIDS Res. Hum. Retrovir., 30, 742, 10.1089/aid.2013.0194

Keele, 2006, Chimpanzee reservoirs of pandemic and nonpandemic HIV-1, Science, 313, 523, 10.1126/science.1126531

Khajehkazemi, 2013, HIV prevalence and risk behaviours among people who inject drugs in Iran: the 2010 National Surveillance Survey, Sex. Transm. Infect., 89, iii29, 10.1136/sextrans-2013-051204

Khan, 2006, HIV-1 subtype A infection in a community of intravenous drug users in Pakistan, BMC Infect. Dis., 6, 164, 10.1186/1471-2334-6-164

Kivelä, 2005, High plasma HIV load in the CRF01-AE outbreak among injecting drug users in Finland, Scand. J. Infect. Dis., 37, 276, 10.1080/00365540410021054

Kivelä, 2007, HIV outbreak among injecting drug users in the Helsinki region: social and geographical pockets, Eur. J. Pub. Health, 17, 381, 10.1093/eurpub/ckl252

Kiwanuka, 2008, Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection, J. Infect. Dis., 197, 707, 10.1086/527416

Korber, 2000, Timing the ancestor of the HIV-1 pandemic strains, Science, 288, 1789, 10.1126/science.288.5472.1789

Kuiken, 2000, Genetic analysis reveals epidemiologic patterns in the spread of human immunodeficiency virus, Am. J. Epidemiol., 152, 814, 10.1093/aje/152.9.814

Kurbanov, 2003, Human immunodeficiency virus in Uzbekistan: epidemiological and genetic analyses, AIDS Res. Hum. Retrovir., 19, 731, 10.1089/088922203769232520

Kusagawa, 1998, Genetic and serologic characterization of HIV type 1 prevailing in Myanmar (Burma), AIDS Res. Hum. Retrovir., 14, 1379, 10.1089/aid.1998.14.1379

Kusagawa, 1999, HIV type 1 env subtype E in Cambodia, AIDS Res. Hum. Retrovir., 15, 91, 10.1089/088922299311772

Laeyendecker, 2005, Molecular epidemiology of HIV-1 subtypes in southern China, J. Acquir. Immune Defic. Syndr., 38, 356

Laga, 2015, The genetic variability of HIV-1 in Kyrgyzstan: the spread of CRF02_AG and subtype A1 recombinants, J. HIV AIDS, 1

Laga, 2015, HIV type 1 subtype A1 dominates in Armenia, Curr. HIV Res., 13, 219, 10.2174/1570162X13666150407142834

Lai, 2016, HIV-1 A1 subtype epidemic in Italy originated from Africa and Eastern Europe and shows a high frequency of transmission chains involving intravenous drug users, PLoS One, 11

Lan, 2003, HIV type 1 isolates from 200 untreated individuals in Ho Chi Minh City (Vietnam): ANRS 1257 Study. Large predominance of CRF01_AE and presence of major resistance mutations to antiretroviral drugs, AIDS Res. Hum. Retroviruses, 19, 925, 10.1089/088922203322493111

Lapovok, 2014, Short communication: molecular epidemiology of HIV type 1 infection in Kazakhstan: CRF02_AG prevalence is increasing in the southeastern provinces, AIDS Res. Hum. Retrovir., 30, 769, 10.1089/aid.2013.0291

Larsen, 2010, Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study, Scand. J. Infect. Dis., 42, 917, 10.3109/00365548.2010.511258

Lau, 2013, Current trends of HIV recombination worldwide, Infect. Dis. Rep., 5, 10.4081/idr.2013.s1.e4

Lazouskaya, 2005, The HIV type 1 epidemic in Belarus: predominance of Eastern European subtype A strains and circulation of subtype B viruses, AIDS Res. Hum. Retrovir., 21, 830, 10.1089/aid.2005.21.830

Li, 2010, Explosive HIV-1 subtype B’ epidemics in Asia driven by geographic and risk group founder events, Virology, 402, 223, 10.1016/j.virol.2010.03.048

Li, 2015, CRF07_BC strain dominates the HIV-1 epidemic in injection drug users in Liangshan Prefecture of Sichuan, China, AIDS Res. Hum. Retroviruses, 31, 479, 10.1089/aid.2014.0120

Liao, 2009, Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam, Virology, 391, 51, 10.1016/j.virol.2009.05.023

Liitsola, 1998, HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad, AIDS, 12, 1907, 10.1097/00002030-199814000-00023

Liitsola, 2000, An AB recombinant and its parental HIV type 1 strains in the area of the former Soviet Union: low requirements for sequence identity in recombination. UNAIDS Virus Isolation Network, AIDS Res. Hum. Retroviruses, 16, 1047, 10.1089/08892220050075309

Liitsola, 2000, An outbreak of the circulating recombinant form AECM240 HIV-1 in the Finnish injection drug user population, AIDS, 14, 2613, 10.1097/00002030-200011100-00028

Lin, 2006, An epidemic of HIV type I CRF07_BC infection among injection drug users in Taiwan, J. Acquir. Immune Defic. Syndr., 42, 248, 10.1097/01.qai.0000214818.80539.da

Linka, 2008, A study of HIV-1 genetic diversity in the Czech Republic: 1986–2007, Cent. Eur. J. Public Health, 16, 175, 10.21101/cejph.a3500

Liu, 2012, Phylodynamics of HIV-1 unique recombinant forms in China–Myanmar border: implication for HIV-1 transmission to Myanmar from Dehong, China, Infect. Genet. Evol., 12, 1944, 10.1016/j.meegid.2012.08.001

Lospitao, 2005, HIV-1 subtypes in Spain: a retrospective analysis from 1995 to 2003, HIV Med., 6, 313, 10.1111/j.1468-1293.2005.00313.x

Lukashov, 1995, Simultaneous introduction of distinct HIV-1 subtypes into different risk groups in Russia, Byelorussia and Lithuania, AIDS, 9, 435, 10.1097/00002030-199509050-00004

Lukashov, 1996, Evidence for HIV type 1 strains of U.S. intravenous drug users as founders of AIDS epidemic among intravenous drug users in northern Europe, AIDS Res. Hum. Retroviruses, 12, 1179, 10.1089/aid.1996.12.1179

Lukashov, 1998, Extreme founder effect in an HIV type 1 subtype A epidemic among drug users in Svetlogorsk, Belarus, AIDS Res. Hum. Retroviruses, 14, 1299, 10.1089/aid.1998.14.1299

Lukashov, 1999, Circulation of subtype A and gagA/envB recombinant HIV type 1 strains among injecting drug users in St. Petersburg, Russia, correlates with geographical origin of infections, AIDS Res. Hum. Retroviruses, 15, 1577, 10.1089/088922299309874

MacArthur, 2014, Interventions to prevent HIV and hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness, Int. J. Drug Policy, 25, 34, 10.1016/j.drugpo.2013.07.001

Mandal, 2002, HIV type 1 subtypes circulating in eastern and northeastern regions of India, AIDS Res. Hum. Retrovir., 18, 1219, 10.1089/08892220260387968

Mathers, 2008, Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review, Lancet, 372, 1733, 10.1016/S0140-6736(08)61311-2

Mathers, 2013, Mortality among people who inject drugs: a systematic review and meta-analysis, Bull. World Health Organ., 91, 102, 10.2471/BLT.12.108282

McCormack, 2015, Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial, Lancet

Memarnejadian, 2015, Transmitted drug resistance mutations in antiretroviral-naïve injection drug users with chronic HIV-1 infection in Iran, PLoS One, 10, 10.1371/journal.pone.0126955

Menu, 1996, HIV type 1 Thai subtype E is predominant in South Vietnam, AIDS Res. Hum. Retrovir., 12, 629, 10.1089/aid.1996.12.629

Menu, 1999, Predominance of CCR5-dependent HIV-1 subtype E isolates in Cambodia, J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 20, 481, 10.1097/00042560-199904150-00011

Mezei, 2011, Molecular epidemiological analysis of env and pol sequences in newly diagnosed HIV type 1-infected, untreated patients in Hungary, AIDS Res. Hum. Retrovir., 27, 1243, 10.1089/aid.2011.0077

Mills, 2011, Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda, Ann. Intern. Med., 155, 209, 10.7326/0003-4819-155-4-201108160-00358

Montavon, 2002, CRF06-cpx: a new circulating recombinant form of HIV-1 in West Africa involving subtypes A, G, K, and J, J. Acquir. Immune Defic. Syndr., 29, 522, 10.1097/00126334-200204150-00014

Motomura, 2000, Emergence of new forms of human immunodeficiency virus type 1 intersubtype recombinants in central Myanmar, AIDS Res. Hum. Retrovir., 16, 1831, 10.1089/08892220050195793

Mousavi, 2010, Surveillance of HIV drug resistance transmission in Iran: experience gained from a pilot study, Arch. Virol., 155, 329, 10.1007/s00705-009-0583-6

Mullick, 2010, Molecular characterization of tat gene and long terminal repeat region of human immunodeficiency virus type-1 detected among the injecting drug users (IDUs) of Manipur, India: identification of BC recombinants, Virus Res., 147, 195, 10.1016/j.virusres.2009.10.024

Murray, 2012, The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis, HIV Med., 13, 89, 10.1111/j.1468-1293.2011.00940.x

Nabatov, 2002, Simultaneous introduction of HIV type 1 subtype A and B viruses into injecting drug users in southern Ukraine at the beginning of the epidemic in the former Soviet Union, AIDS Res. Hum. Retrovir., 18, 891, 10.1089/08892220260190380

Naderi, 2006, Molecular and phylogenetic analysis of HIV-1 variants circulating among injecting drug users in Mashhad-Iran, Infect. Agent. Cancer, 1, 4, 10.1186/1750-9378-1-4

Neogi, 2011, Genetic architecture of HIV-1 genes circulating in north India & their functional implications, Indian J. Med. Res., 134, 769, 10.4103/0971-5916.92624

Neogi, 2012, Molecular epidemiology of HIV-1 subtypes in India: origin and evolutionary history of the predominant subtype C, PLoS One, 7, 10.1371/journal.pone.0039819

Niculescu, 2015, Recent HIV-1 outbreak among intravenous drug users in Romania: evidence for cocirculation of CRF14_BG and subtype F1 strains, AIDS Res. Hum. Retrovir., 31, 488, 10.1089/aid.2014.0189

Nikolopoulos, 2008, HIV epidemiology in Greece, Future Microbiol, 3, 507, 10.2217/17460913.3.5.507

Nikolopoulos, 2015, National income inequality and declining GDP growth rates are associated with increases in HIV diagnoses among people who inject drugs in europe: a panel data analysis, PLoS One, 10, 10.1371/journal.pone.0122367

Nikolopoulos, 2015, Big events in Greece and HIV infection among people who inject drugs, Subst. Use Misuse, 50, 825, 10.3109/10826084.2015.978659

Novitsky, 1998, Molecular epidemiology of an HIV-1 subtype A subcluster among injection drug users in the Southern Ukraine, AIDS Res. Hum. Retrovir., 14, 1079, 10.1089/aid.1998.14.1079

Nsanzimana, 2015, Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study, Lancet Glob. Health, 3, e169, 10.1016/S2214-109X(14)70364-X

Ou, 1993, Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand, Lancet, 341, 1171, 10.1016/0140-6736(93)91001-3

Palma, 2007, Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal, Infect. Genet. Evol., 7, 391, 10.1016/j.meegid.2007.01.009

Pandrea, 2001, HIV type 1 genetic diversity and genotypic drug susceptibility in the Republic of Moldova, AIDS Res. Hum. Retrovir., 17, 1297, 10.1089/088922201750461375

Pang, 2012, Extensive and complex HIV-1 recombination between B’, C and CRF01_AE among IDUs in south-east Asia, AIDS, 26, 1121, 10.1097/QAD.0b013e3283522c97

Paraskevis, 2007, Increasing prevalence of HIV-1 subtype A in Greece: estimating epidemic history and origin, J. Infect. Dis., 196, 1167, 10.1086/521677

Paraskevis, 2011, HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report, Euro Surveill., 16, 10.2807/ese.16.36.19962-en

Paraskevis, 2013, Economic recession and emergence of an HIV-1 outbreak among drug injectors in athens metropolitan area: a longitudinal study, PLoS One, 8, 10.1371/journal.pone.0078941

Paraskevis, 2015, Enhanced HIV-1 surveillance using molecular epidemiology to study and monitor HIV-1 outbreaks among intravenous drug users (IDUs) in Athens and Bucharest, Infect. Genet. Evol., 35, 109, 10.1016/j.meegid.2015.08.004

Parczewski, 2016, Distribution and time trends of HIV-1 variants in Poland: characteristics of non-B clades and recombinant viruses, Infect. Genet. Evol., 39, 232, 10.1016/j.meegid.2016.02.001

Peeters, 1997, Geographical distribution of HIV-1 group O viruses in Africa, AIDS, 11, 493, 10.1097/00002030-199704000-00013

Peeters, 2013, The origin and molecular epidemiology of HIV, Expert Rev. Anti-Infect. Ther., 11, 885, 10.1586/14787210.2013.825443

Pérez-Alvarez, 2003, High incidence of non-B and recombinant HIV-1 strains in newly diagnosed patients in Galicia, Spain: study of genotypic resistance, Antivir. Ther., 8, 355, 10.1177/135965350300800413

Plantier, 2009, A new human immunodeficiency virus derived from gorillas, Nat. Med., 15, 871, 10.1038/nm.2016

Reinis, 2001, Genetic subtypes of HIV type 1 viruses circulating in the Czech Republic, AIDS Res. Hum. Retrovir., 17, 1305, 10.1089/088922201750461384

Renjifo, 2004, Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D, AIDS, 18, 1629, 10.1097/01.aids.0000131392.68597.34

Rhodes, 2005, Transition and the HIV risk environment, BMJ, 331, 220, 10.1136/bmj.331.7510.220

Roques, 2002, Phylogenetic analysis of 49 newly derived HIV-1 group O strains: high viral diversity but no group M-like subtype structure, Virology, 302, 259, 10.1006/viro.2002.1430

Roques, 2004, Phylogenetic characteristics of three new HIV-1 N strains and implications for the origin of group N, AIDS, 18, 1371, 10.1097/01.aids.0000125990.86904.28

Rumyantseva, 2009, Epidemiological networks and drug resistance of HIV type 1 in Krasnoyarsk region, Russia, AIDS Res. Hum. Retroviruses, 25, 931, 10.1089/aid.2009.0075

Saad, 2006, Genetic forms of HIV Type 1 in the former Soviet Union dominate the epidemic in Azerbaijan, AIDS Res. Hum. Retrovir., 22, 796, 10.1089/aid.2006.22.796

Saad, 2006, Molecular epidemiology of HIV Type 1 in Ukraine: birthplace of an epidemic, AIDS Res. Hum. Retrovir., 22, 709, 10.1089/aid.2006.22.709

Sahbandar, 2009, Current HIV type 1 molecular epidemiology profile and identification of unique recombinant forms in Jakarta, Indonesia, AIDS Res. Hum. Retroviruses, 25, 637, 10.1089/aid.2008.0266

Samji, 2013, Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada, PLoS One, 8, 10.1371/journal.pone.0081355

Sanders-Buell, 2007, A nascent HIV type 1 epidemic among injecting drug users in Kabul, Afghanistan is dominated by complex AD recombinant strain, CRF35_AD, AIDS Res. Hum. Retrovir., 23, 834, 10.1089/aid.2006.0299

Sanders-Buell, 2010, Distinct circulating recombinant HIV-1 strains among injecting drug users and sex workers in Afghanistan, AIDS Res. Hum. Retrovir., 26, 605, 10.1089/aid.2009.0226

Saraswathy, 2000, Human immunodeficiency virus type 1 subtypes among Malaysian intravenous drug users, Southeast Asian J. Trop. Med. Public Health, 31, 283

Sarkar, 2009, Implementation of a multiregion hybridization assay to characterize HIV-1 strains detected among injecting drug users in Manipur, India, Intervirology, 52, 175, 10.1159/000224645

Sarker, 2008, Molecular evidence for polyphyletic origin of human immunodeficiency virus type 1 subtype C in Bangladesh, Virus Res., 135, 89, 10.1016/j.virusres.2008.02.010

Sarrami-Forooshani, 2006, Molecular analysis and phylogenetic characterization of HIV in Iran, J. Med. Virol., 78, 853, 10.1002/jmv.20634

Shah, 2011, Antiretroviral drug resistance mutations among treated and treatment-naive patients in Pakistan: diversity of the HIV type 1 pol gene in Pakistan, AIDS Res. Hum. Retrovir., 27, 1277, 10.1089/aid.2010.0324

Shahid, 2011, HIV-1 circulating recombinant form in Nepal, J. Virol., 85, 8458, 10.1128/JVI.05108-11

Sharp, 2011, Origins of HIV and the AIDS pandemic, Cold Spring Harb. Perspect. Med., 1, a006841, 10.1101/cshperspect.a006841

Shen, 2011, Origin and dynamics of HIV-1 subtype C infection in India, PLoS One, 6, 10.1371/journal.pone.0025956

Shiino, 2014, Phylodynamic analysis reveals CRF01_AE dissemination between Japan and neighboring Asian countries and the role of intravenous drug use in transmission, PLoS One, 9, 10.1371/journal.pone.0102633

Simon, 1998, Identification of a new human immunodeficiency virus type 1 distinct from group M and group O, Nat. Med., 4, 1032, 10.1038/2017

Smoleń-Dzirba, 2012, Molecular epidemiology of recent HIV-1 infections in southern Poland, J. Med. Virol., 84, 1857, 10.1002/jmv.23395

Smolskaya, 2006, HIV epidemiology in the Northwestern Federal District of Russia: dominance of HIV type 1 subtype A, AIDS Res. Hum. Retrovir., 22, 1074, 10.1089/aid.2006.22.1074

Stanojevic, 2012, HIV-1 molecular epidemiology in the Balkans: a melting pot for high genetic diversity, AIDS Rev., 14, 28

Stephenson, 2013, A global approach to HIV-1 vaccine development, Immunol. Rev., 254, 295, 10.1111/imr.12073

Strathdee, 2010, Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions, Curr. HIV/AIDS Rep., 7, 99, 10.1007/s11904-010-0043-7

Strathdee, 2006, Complex emergencies, HIV, and substance use: no “big easy” solution, Subst. Use Misuse, 41, 1637, 10.1080/10826080600848116

Subbarao, 1998, HIV type 1 in Thailand, 1994–1995: persistence of two subtypes with low genetic diversity, AIDS Res. Hum. Retrovir., 14, 319, 10.1089/aid.1998.14.319

Tagliamonte, 2007, HIV type 1 subtype A epidemic in injecting drug user (IDU) communities in Iran, AIDS Res. Hum. Retrovir., 23, 1569, 10.1089/aid.2007.0169

Takebe, 2003, High prevalence of diverse forms of HIV-1 intersubtype recombinants in Central Myanmar: geographical hot spot of extensive recombination, AIDS, 17, 2077, 10.1097/00002030-200309260-00009

Takebe, 2004, Molecular epidemiology of HIV: tracking AIDS pandemic, Pediatr. Int., 46, 236, 10.1046/j.1442-200x.2004.01869.x

Takebe, 2010, Reconstructing the epidemic history of HIV-1 circulating recombinant forms CRF07_BC and CRF08_BC in East Asia: the relevance of genetic diversity and phylodynamics for vaccine strategies, Vaccine, 28, B39, 10.1016/j.vaccine.2009.07.101

Tee, 2005, Emergence of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia, AIDS, 19, 119, 10.1097/00002030-200501280-00003

Tee, 2005, The evolving molecular epidemiology of HIV type 1 among injecting drug users (IDUs) in Malaysia, AIDS Res. Hum. Retrovir., 21, 1046, 10.1089/aid.2005.21.1046

Tee, 2006, Identification of a novel circulating recombinant form (CRF33_01B) disseminating widely among various risk populations in Kuala Lumpur, Malaysia, J. Acquir. Immune Defic. Syndr., 43, 523, 10.1097/01.qai.0000242451.74779.a7

2008, Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies, Lancet, 372, 293, 10.1016/S0140-6736(08)61113-7

Thomson, 2007, Increasing HIV-1 genetic diversity in Europe, J. Infect. Dis., 196, 1120, 10.1086/521683

Thomson, 2001, HIV-1 genetic diversity in Galicia Spain: BG intersubtype recombinant viruses circulating among injecting drug users, AIDS, 15, 509, 10.1097/00002030-200103090-00010

Thomson, 2007, New insights into the origin of the HIV type 1 subtype A epidemic in former Soviet Union's countries derived from sequence analyses of preepidemically transmitted viruses, AIDS Res. Hum. Retrovir., 23, 1599, 10.1089/aid.2007.0166

Tovanabutra, 2001, First CRF01_AE/B recombinant of HIV-1 is found in Thailand, AIDS, 15, 1063, 10.1097/00002030-200105250-00018

Tovanabutra, 2003, A new circulating recombinant form, CRF15_01B, reinforces the linkage between IDU and heterosexual epidemics in Thailand, AIDS Res. Hum. Retrovir., 19, 561, 10.1089/088922203322230923

Tovanabutra, 2004, The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002, AIDS Res. Hum. Retrovir., 20, 465, 10.1089/088922204323087705

Tovanabutra, 2007, Identification of CRF34_01B, a second circulating recombinant form unrelated to and more complex than CRF15_01B, among injecting drug users in northern Thailand, AIDS Res. Hum. Retrovir., 23, 829, 10.1089/aid.2006.0300

Tripathy, 2005, Subtype B and subtype C HIV type 1 recombinants in the northeastern state of Manipur, India, AIDS Res. Hum. Retroviruses, 21, 152, 10.1089/aid.2005.21.152

United Nations Office on Drugs and Crime (UNODC), 2014, 10.18356/bdf42380-en

Vallari, 2010, Four new HIV-1 group N isolates from Cameroon: prevalence continues to be low, AIDS Res. Hum. Retrovir., 26, 109, 10.1089/aid.2009.0178

Vallari, 2011, Confirmation of putative HIV-1 group P in Cameroon, J. Virol., 85, 1403, 10.1128/JVI.02005-10

Van Heuverswyn, 2006, Human immunodeficiency viruses: SIV infection in wild gorillas, Nature, 444, 164, 10.1038/444164a

Vermund, 2012, The HIV epidemic: high-income countries, Cold Spring Harb. Perspect. Med., 2, 10.1101/cshperspect.a007195

Weber, 2015, Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study, HIV Med., 16, 137, 10.1111/hiv.12184

Wolfe, 2010, Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward, Lancet, 376, 355, 10.1016/S0140-6736(10)60832-X

Wood, 2008, Highly active antiretroviral therapy and survival in HIV-infected injection drug users, JAMA, 300, 550, 10.1001/jama.300.5.550

Worobey, 2008, Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960, Nature, 455, 661, 10.1038/nature07390

Yerly, 2004, HIV-1 co/super-infection in intravenous drug users, AIDS, 18, 1413, 10.1097/01.aids.0000131330.28762.0c

Yu, 1999, Emerging HIV infections with distinct subtypes of HIV-1 infection among injection drug users from geographically separate locations in Guangxi Province, China, J. Acquir. Immune Defic. Syndr., 22, 180, 10.1097/00126334-199910010-00011

Zarandia, 2006, HIV-1 genetic diversity and genotypic drug susceptibility in the Republic of Georgia, AIDS Res. Hum. Retrovir., 22, 470, 10.1089/aid.2006.22.470

Zetterberg, 2004, Two viral strains and a possible novel recombinant are responsible for the explosive injecting drug use-associated HIV type 1 epidemic in Estonia, AIDS Res. Hum. Retrovir., 20, 1148, 10.1089/aid.2004.20.1148

Zheng, 1994, Injecting drug use and HIV infection in southwest China, AIDS, 8, 1141, 10.1097/00002030-199408000-00017

Zhou, 2014, Diverse forms of HIV-1 among Burmese long-distance truck drivers imply their contribution to HIV-1 cross-border transmission, BMC Infect. Dis., 14, 463, 10.1186/1471-2334-14-463

Zhu, 1998, An African HIV-1 sequence from 1959 and implications for the origin of the epidemic, Nature, 391, 594, 10.1038/35400